Italian Society of Addiction, Cuneo, Italy.
Eur Addict Res. 2011;17(2):80-9. doi: 10.1159/000321465. Epub 2010 Dec 17.
While psychiatric comorbidity has been shown to produce a negative impact on the outcome of opioid use disorders, longitudinal studies carried out in the context of methadone maintenance treatment programs (MMTP) to evaluate outcomes strictly linked to methadone efficacy have not demonstrated a similar negative influence. To verify whether results obtained considering psychopathology in terms of formal psychiatric diagnoses were replicated when assessing psychopathology in terms of global psychiatric severity, a retrospective cohort study was designed. 259 patients commencing methadone maintenance treatment were divided into two groups on the basis of SCL-90 severity score and compared for retention in treatment, toxicological urine test results and psychological/psychiatric status throughout a one year period of observation. The results of the study suggest that patients in MMTP with high psychiatric severity are not characterized by a lower retention in treatment or higher substance use than those with low psychiatric severity. Moreover, during treatment high severe psychiatric patient status appears to improve significantly for all psychological/psychiatric dimensions explored by SCL-90. These results are consistent with those obtained in previous studies on the efficacy of MMTP, comprehensive of psychiatric care, irrespective of the severity of psychopathology exhibited by patients at the beginning of treatment.
虽然精神共病已被证明会对阿片类药物使用障碍的治疗结果产生负面影响,但在美沙酮维持治疗计划(MMTP)背景下进行的评估与美沙酮疗效严格相关的结果的纵向研究并未显示出类似的负面影响。为了验证在评估精神病理学时考虑正式精神科诊断的结果是否可以复制,当评估总体精神科严重程度时,进行了一项回顾性队列研究。根据 SCL-90 严重程度评分,将 259 名开始美沙酮维持治疗的患者分为两组,并在一年的观察期间比较他们在治疗中的保留率、毒理学尿液测试结果和心理/精神病学状况。该研究的结果表明,与低精神严重程度的患者相比,MMTP 中精神严重程度高的患者在治疗保留率或物质使用方面没有较低的特征。此外,在治疗过程中,高严重精神科患者的状况似乎在 SCL-90 探索的所有心理/精神病学维度上都有显著改善。这些结果与之前对包括精神科护理在内的 MMTP 疗效的研究结果一致,而与患者在治疗开始时表现出的精神病理学严重程度无关。